PIC Therapeutics: Funding, Investors & Team (Sep 2026)
PIC Therapeutics is a biotechnology company focused on transforming the treatment of cancer through the selective modulation of oncogene translation. The company is modulating oncogene translation to dramatically improve cancer patient outcomes. Their precision-based therapeutics target the “master switch” of cancer signaling pathways, selectively blocking oncogene protein production by modulating the Pre-Initiation Complex (PIC) that drives their mRNA translation. Its selective approach has the potential to simultaneously modulate multiple oncogenic drivers leading to a powerful new generation of cancer-treating therapeutics. PIC Therapeutics was founded in 2016 and is headquartered in
PIC Therapeutics has raised $40.0M across 2 funding rounds on record, the most recent a Series A of $35.0M announced in Oct 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
PIC Therapeutics Company Profile and Key Stats
Latest funding round on record: Oct 2022.
PIC Therapeutics Funding Rounds
PIC Therapeutics raised $5.0M in an undisclosed round announced in Apr 2020.
2.5 years later, a Series A of $35.0M was announced in Oct 2022.
PIC Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
PIC Therapeutics Funding Compared to Other Biotechnology Startups
PIC Therapeutics' latest round of $35.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like PIC Therapeutics in Biotechnology and Natick
Companies Similar to PIC Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
PIC Therapeutics Funding FAQs
What does PIC Therapeutics do?
PIC Therapeutics is a biotechnology company focused on transforming the treatment of cancer through the selective modulation of oncogene translation. The company is modulating oncogene translation to dramatically improve cancer patient outcomes. Their precision-based therapeutics target the “master switch” of cancer signaling pathways, selectively blocking oncogene protein production by modulating the Pre-Initiation Complex (PIC) that drives their mRNA translation. Its selective approach has the potential to simultaneously modulate multiple oncogenic drivers leading to a powerful new generation of cancer-treating therapeutics. PIC Therapeutics was founded in 2016 and is headquartered in
How much funding has PIC Therapeutics raised?
PIC Therapeutics has raised $40.0M across 2 rounds on record. The most recent is a Series A of $35.0M announced in Oct 2022.
When did PIC Therapeutics last raise funding?
PIC Therapeutics' most recent funding round on record is a Series A of $35.0M, announced in Oct 2022.
Who is the CEO of PIC Therapeutics?
Katherine S Bowdish is listed as CEO at PIC Therapeutics.
Where is PIC Therapeutics headquartered?
PIC Therapeutics is based in Natick, Massachusetts, United States.
How many employees does PIC Therapeutics have?
PIC Therapeutics is in the 1-10 employee band.
How does PIC Therapeutics' funding compare to other Biotechnology startups?
PIC Therapeutics' latest round of $35.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's PIC Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for PIC Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.